The anticryptococcal activity of peripheral blood polymorphonuclear leukocytes (PMN) 
surrounded by greater than five PMN. Thus, phagocyte-mediated inhibition of cryptococcal growth is enhanced on endothelial monolayers compared with plastic surfaces, possibly as a result of differences in phagocyte viability and patterns of binding. Bolstering the activity of circulating phagocytes by stimulating endothelial cells may be of relevance in the treatment of patients with or at risk for cryptococcemia.
Cryptococcal infections are a significant cause of morbidity and mortality in individuals with compromised cellmediated immunity, especially those with hematologic malignancies, steroid use, and human immunodeficiency virus infection. Following respiratory acquisition of the organism, the pulmonary system provides the first line of defense against cryptococcal disease (5, 19, 36) . In experimental murine pulmonary infections, early clearance of Cryptococcus neoformans is rapidly accomplished by polymorphonuclear leukocytes (PMN), while mononuclear cells predominate later in the inflammatory infiltrate (11) . If the organism overwhelms the lungs' defenses, hematogenous dissemination to the meninges and other organ systems may occur. Indeed, patients with cryptococcosis frequently have cryptococcemia, which, when found, is a poor prognostic sign (7, 29) . Thus, peripheral blood phagocytes presumably form an important defense against disseminated cryptococcosis.
Other investigators have demonstrated that PMN and monocytes have fungicidal activity against C. neoforrnans in in vitro assays of 4 h or less (8, 28) . However, in those assays, a significant percentage of the organisms was not killed and the fate of the surviving yeast cells was not determined. Moreover, phagocytes and fungi were coincubated in plastic reaction vessels. Recent studies have emphasized the importance of the culture surface to phagocyte function. For example, monocyte-derived macrophages cultured on fibronectin surfaces completely inhibited the growth of C. neoformans opsonized with pooled human serum (PHS), while those cultured on plastic did not (20) .
The physiological function of blood PMN is critically * Corresponding author.
dependent upon their ability to interact with endothelial cells. Recognition of PMN by endothelial cells is promoted by over 10 adhesion receptors (8, 24, (30) (31) (32) . In the presence of inflammation, many of the adhesion receptors are upregulated so as to facilitate intercellular binding and subsequent extravasation of PMN across the endothelium (9, 26, 30, 32 Mitchell. This cryptococcal strain has been shown to be susceptible to killing by human PMN and monocytes (28) . The organism was maintained on asparagine minimal agar medium at 30°C, as in previous studies (18, (20) (21) (22) . Under these conditions, the diameter of the organisms and width of the capsule were 4.35 ± 2.05 ,um and 0.48 ± 0.19 ,um (mean ± standard deviation), respectively.
HUVEC. Human umbilical vein endothelial cells (HU-VEC; Cell Systems, Kirkland, Wash.) were harvested by using collagenase from a pool of 30 umbilical cords and were used at cell passages 2 and 3. The monolayers were maintained in culture with medium consisting of M199 (GIBCO, Grand Island, N.Y.), 20% heat-inactivated fetal calf serum, endothelial growth factor (15 p,g/ml), penicillin (100 U/ml), streptomycin (100 ,ug/ml), thymidine (1 ,uM), heparin (10 ,ug/ml), N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES) buffer (10 mM), and glutamine (2 mM) in tissue culture flasks (25 cm2, number 25106; Coming Glass Works), coated with 5% gelatin (Difco Laboratories, Detroit, Mich.). HUVEC were grown to confluence in tissue culture wells precoated with 5% gelatin. Purity was verified by indirect immunofluorescence labeling with polyclonal rabbit immunoglobulin G directed against human factor VIII.
IL-1 stimulation of HUVEC. Cultured HUVEC monolayers were incubated with IL-1 (20 U/ml) for 4 or 24 h at 37°C. Unless stated otherwise, IL-1-treated HUVEC refers to HUVEC treated for 4 h. Treated monolayers were then washed three times with medium to remove residual IL-1.
Isolation of PMN and monocytes. Human peripheral blood was obtained by venipuncture from normal volunteers and anticoagulated with 10 U of heparin per ml of blood. PMN were separated by centrifugation (550 x g) on a FicollHypaque density gradient, subjected to saline lysis, and resuspended in medium at the desired concentration (27) . Monocytes were obtained by the method of Freundlich et al. (10) . Briefly, heparinized whole blood was centrifuged at 1,000 x g at 4°C for 15 min. The plasma supernatant was used to coat a plastic petri dish previously treated with 2% gelatin. The buffy coat was diluted 1:3 with phosphatebuffered saline (PBS; GIBCO) and centrifuged on a FicollHypaque density gradient. The resultant monolayer was washed, resuspended in RPMI 1640 supplemented with 20% fetal calf serum, and incubated for 1 h at 37°C on the gelatin-plasma-coated petri dish. Nonadherent cells were aspirated. Adherent monocytes were loosened with 0.02% EDTA, recovered by gentle scraping with a rubber policeman, washed, and resuspended in RPMI 1640 at the desired concentration. Monocytes obtained by this method were 73% t 4% (mean ± standard error of the mean [SEM] of three experiments) pure as determined by nonspecific esterase staining (Sigma Diagnostics, kit 91-A). The remaining cells had the characteristics of lymphocytes as determined by flow cytometry and hematoxylin staining.
Growth inhibition assay. PMN or monocytes were added to uncoated polystyrene wells (hereafter referred to as plastic surfaces) and to wells containing untreated and IL-1-treated HUVEC monolayers. Each sample was prepared in triplicate. In some experiments, saturating concentrations of MAb specific for GM-CSF (50 jig/ml), p,g/ml), ICAM-1 (25 jig/ml), ELAM-1 (blocking, 20 p,g/ml), ELAM-1 (nonblocking, 20 ,ug/ml), CD11a (1:200 ascites dilution), CD18 (1:200 ascites dilution), or NMMA (100 jiM)
were added to the IL-1-stimulated endothelial monolayer for 20 to 30 min prior to the addition of PMN and were allowed to remain throughout the subsequent incubation. After 1 h, the well contents were challenged with 104 CFU of C.
neoformans in the presence of 10% PHS. Following an 18-h incubation at 37°C (and at 4°C for the control specimens) 0.1% Triton X-100 was added to the wells, and the contents of the wells were transferred to test tubes containing 1 ml of distilled H20 and sonicated under conditions shown to lyse the leukocytes without affecting fungal viability. Microscopic observations ensured that the entire contents of the wells were transferred, cell lysis was complete, and clumping of organisms did not occur. Dilutions and spread plates were then performed, and CFU were counted after 72 h. Percent growth was then calculated as follows: [(experimental CFU)/(mean CFU at 40C) -1] x 100. Thus, a value of zero indicates that the numbers of CFU at the start and conclusion of the incubation were the same. Values of 100, 200, and 400% indicate that the fungi underwent an average of one, two, and three replications, respectively. Negative values indicate that the number of CFU decreased during the incubation, and therefore fungal killing had taken place (17, 20, 21) . However, with this assay, the exact extent of killing or fungistasis cannot be quantitated since, during the 18-h incubation period, some fungi may grow while others are killed.
Detection of nitric oxide. Production of nitrite, a stable end-product of nitric oxide generation, was determined in supernatants from endothelial cells incubated for up to 72 h by a colorimetric assay (15) . Briefly, equal amounts of supernatant and Griess reagent were incubated for 10 min, and A546 was determined.
PMN viability assay. PMN were suspended at 107/ml in PBS containing 0.2% bovine serum albumin and 100 pCi of sodium chromate (51Cr; New England Nuclear, Boston, Mass.) per ml for 1 h with rocking at 37°C (6 (Fig. 1) . In the absence of PMN, the magnitude of fungal growth on an endothelial surface did not differ significantly from growth on a plastic surface, even if the endothelial cells were pretreated with IL-1. However, the addition of 10' PMN to plastic and endothelial cell-lined wells resulted in significantly less fungal growth on the HUVEC surface than on plastic. This inhibition was further enhanced when the monolayer was pretreated for 4 h (but not when it was pretreated for 24 h) with IL-1. Pretreatment of HUVEC with IL-1 also enhanced the inhibition of cryptococcal growth mediated by PMN on an IL-1-stimulated HUVEC monolayer ( Table 4 ). The anticryptococcal activity of PMN on stimulated HUVEC was not affected by the addition of NMMA (Table  4) . NMMA inhibits synthesis of nitric oxide (15), a reactive nitrogen intermediate with known anticryptococcal activity (12) . Moreover, nitric oxide was not detected in supernatants from IL-1-stimulated and unstimulated HUVEC (data not shown).
Quantitation of 51Cr release as a measure of PMN viability.
The viability assay measured PMN survival on plastic and endothelial surfaces under the same conditions used in the growth inhibition assay (Fig. 2) . In five separate experiments using two PMN concentrations, 51Cr release was significantly greater for PMN incubated on plastic than for those incubated on untreated and IL-i-stimulated HUVEC monolayers. Although these results were significant, there was considerable experiment-to-experiment variability. Thus, in three of the five experiments, only small differences were noted in 51Cr release between the groups, whereas in the other two experiments 51Cr release differed by as much as 36% (data not shown).
Binding assay. We next measured the ability of PMN to bind C. neofornans on plastic, HUVEC, and IL-i-treated HUVEC surfaces ( Fig. 3 and 4) . When (Fig. 5) . No significant difference in growth was apparent when 105 monocytes were incubated on HUVEC compared with plastic. However, when the number of monocytes was increased to 3.3 x 105/well and 1 x 106/well, cryptococcal growth was significantly less on the HUVEC monolayer than on plastic. Results were similar regardless of whether the HUVEC monolayer was stimulated with IL-1 (data not shown). As with the PMN studies, when these experiments were conducted with a 2-h rather than an 18-h incubation, no difference in the number of CFU was observed on endothelial versus plastic surfaces (data not shown).
DISCUSSION
The data presented here demonstrate that the anticryptococcal activity of peripheral blood phagocytes is significantly enhanced when cultured on an endothelial monolayer compared with a plastic surface. The inhibition of cryptococcal growth in the presence of PMN (but not monocytes) is further enhanced when the endothelial monolayer is stimulated with IL-1. In the absence of peripheral blood phagocytes, HUVEC, whether stimulated with IL-1 or in the basal state, are devoid of anticryptococcal activity. IL-1 stimulation of a HUVEC monolayer enhances the adhesiveness of the monolayer for both PMN and monocytes (2, 3). We evaluated endothelial adhesion molecules ELAM-1 and ICAM-1 and leukocyte integrins CDiia and CD18 as possible contributors to the observed antifungal activity. We postulated that IL-1-promoted PMN adhesion to endothelial cell surface molecules would activate the PMN, resulting in enhanced anticryptococcal activity. However, blocking antibodies directed against ELAM-1, ICAM-1, or CD11a did not inhibit antifungal activity, whereas CD18 MAb had an effect only at the higher PMN concentration evaluated. It should be noted, though, that cell surface molecules not tested, such as the recently described ICAM-R (34) or other as-yet-undiscovered adhesins, may contribute to the enhanced activity.
During inflammation, endothelial cells are activated by various stimuli to secrete the neutrophil-activating cytokines IL-1, IL-8, and GM-CSF (25, 31) . To examine the potential contribution of these cytokines to the enhanced anticryptococcal activity manifested by PMN in the presence of activated HUVEC, we tested the effects of recombinant cytokines, neutralizing anticytokine antibodies, and supernatants obtained from stimulated HUVEC. Recombinant IL-1, at concentrations of 0.2 and 20 U/ml, activated neutrophils for enhanced antifungal activity, although the effects were modest (Table 2) . Similarly, IL-8, at the highest concentration tested, significantly activated PMN for enhanced activity ( Table 3 ). The inability of supernatants obtained from stimulated HUVEC to augment PMN antifungal activity and the lack of effect of neutralizing antibodies directed against IL-8 and GM-CSF (Table 4) argue against a major role for endothelial cell-derived cytokines in our system. However, a role for cytokines is not precluded, as it remains possible that endothelial cell-derived cytokines are produced locally in high concentrations or at areas of tight contact between HUVEC and PMN. In any event, our data demonstrating the capacity of IL-1 and IL-8 to enhance the anticryptococcal activity of PMN underscore the potential role of these cytokines in modulating host defenses against cryptococcosis. IL-1 and/or IL-8 derived from endothelial The reactive nitrogen intermediate nitric oxide has been shown to contribute to the ability of activated murine macrophages to inhibit and kill C. neoformans (12, 18) . Recently, the machinery for generating nitric oxide in human endothelial cells has been demonstrated (13) . However, two lines of evidence suggest that generation of nitric oxide was not critical for the enhanced antifungal effects of PMN seen when HUVEC were present. First, addition of NMMA, a competitive inhibitor of nitric oxide synthesis, had no effect in our system. Second, nitrite (a sensitive marker for nitric oxide generation) was not present in detectable quantities in the supernatants of IL-1-treated HUVEC.
The finding that PMN viability, as measured by 51Cr release, was significantly less on plastic than on HUVEC (Fig. 2) raises the possibility that the diminished antifungal activity of PMN cultured on plastic was due, at least in part, to greater death of the PMN over the course of the 18-h assay. Other investigators have shown that culture conditions can greatly influence the long-term viability and antimicrobial activity of PMN (16) . Conversely, PMN death has been postulated to be beneficial to host defenses by causing release of calprotectin, a PMN cytosolic protein with antimicrobial properties (33) . Monocytes per well 
